Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when he expects NICE to conclude its deliberations on the use of Sunitinib; what the cost is of providing Sunitinib for a 12 month period; and what estimate he has made of the number of people who could benefit from Sunitinib being approved by NICE.
The information requested is provided in the attached table.